Hasil Pencarian  ::  Simpan CSV :: Kembali

Abstrak :
Latar belakang: Inflamasi memegang peranan penting dalam IMA-EST, terutama kejadia cedera reperfusi. Kolkisin merupakan sediaan obat anti inflamasi, yang dapat menekan inflamasi saat terjadi cedera reperfusi. Kami menilai keefektivan dari pemberian kolkisin pada pasien IMA-EST yang menjalani IKPP dalam menekan cedera reperfusi. Metode: Penelitian ini merupakan uji klinis, tersamar ganda, dengan plasebo, yang dilakukan multisenter di dua rumah sakit di Jakarta dengan fasilitas IKPP dari Desember 2022 hingga April 2023. Pasien IMA-EST yan menjalani IKPP diberikan dosis muat kolkisin 2 mg, kemudian dosis pemeliharaan 2x0,5 mg selama 2 hari, dan amilum pada kelompok plasebo. Pasien diamati kejadian cedera reperfusi berupa TIMI flow, kejadian aritmai, syok dan aritmia akibat reperfusi. Hasil: Sebanyak 77 subyek IMA-EST dengan rerata usia 55.2 ± 9.9 tahun menjalani IKPP. 37 subyek mendapat kolkisin, 40 subyek mendapat placebo. Kebanyakan subjek ialah laki-laki (77.5%), menderita 3 vessel disease (44,1%), oklusi di LAD ( 53,2%). Pemberian kolkisin tidak berhasil menurunkan kejadia cedera iskemia reperfusi (51.5% vs. 42.4%; p = 0.437). Analisi komorbiditas ( hipertensi, gagal ginjal, diabetes mellitus, dan obesitas) dan hasil angiografi ( jumlah pembuluh darah coroner yang sakit, diameter pembuluh darah, dan lokasi penyumbatan yang menyebabkan IMA-EST) tidak berhasil menunjukkan kemaknaan secara statistic. Kejadian efek samping sama pada kedua kelompok (21.6% vs. 15%). Kesimpulan: Pemberian kolkisin pada pasien IMA-EST yang menjalani IKPP tidak berhasil menurunkan kejadian cedera reperfusi. ......Background: Inflammation plays a role in ST-segment elevation myocardial infarction (STEMI), especially in reperfusion injury (RI). Colchicine, an anti-inflammatory drug, can suppress inflammation during RI. We assessed the effectiveness of administering colchicine to STEMI patients undergoing primary percutaneous coronary intervention (PPCI) in suppressing RI events. Methods: This study was a randomized, double-blind, placebo-controlled clinical trial conducted in a multicenter manner at two hospitals in Jakarta with IKPP facilities from December 2022 to April 2023. STEMI patients that underwent PPCI received 2 g of colchicine as a loading dose and a maintenance dose of 0.5 g every 12 hours for two days or amylum at a similar dose. Patients were observed for RI events (low-flow thrombolysis in myocardial infarction (0–2) during angiography procedure, reperfusion arrhythmia, cardiogenic shock, or persistent chest pain). Results: Seventy-seven STEMI patients with a mean age of 55.2 ± 9.9 years underwent PPCI. Of these patients, 37 received colchicine, and 40 received a placebo. Most subjects were male (77.5%), suffered three-vessel disease (44.15%), and occlusion in left anterior descending coronary artery (53.24%). Colchicine was found to fail to reduce the incidence of ischemia-RI (51.5% vs. 42.4%; p = 0.437). Analysis of comorbidities (hypertension, chronic kidney disease, diabetes mellitus, and obesity) and angiography results (vessel disease, lesion diameter, and culprit artery) failed to demonstrate a statistical difference in RI. Side effects were similar in the colchicine and placebo groups (21.6% vs. 15%). Conclusion: Colchicine administration in STEMI patients undergoing PPCI failed to reduce RI.

Abstrak :
Kondisi infark miokard akut (IMA) sering disertai hiperglikemia yang meningkatkan risiko aritmia maligna melalui mekanisme yang diduga berupa kerusakan miokard, perubahan kanal ion dan peningkatan respons inflamasi. Penelitian mengenai hubungan hiperglikemia akut dengan kejadian aritmia maligna pada pasien dengan sindrom koroner akut (SKA) sudah banyak dilakukan, namun pada pasien IMA yang merupakan populasi khusus SKA dan memiliki risiko aritmia maligna lebih tinggi, belum ada penelitian yang menelaah peran kerusakan miokard, perubahan kanal ion dan peningkatan respons inflamasi sebagai patomekanisme terjadinya aritmia maligna pada pasien IMA. Tujuan penelitian ini adalah untuk menentukan pengaruh hiperglikemia akut terhadap kejadian aritmia maligna, troponin I, VLP, strain ekokardiografi, perubahan kanal ion (CaMKII) dan hsCRP. Penelitian ini juga bertujuan menilai pengaruh troponin I, VLP, GLS, CaMKII dan hsCRP terhadap kejadian aritmia maligna pada pasien IMA dengan hiperglikemia akut. Penelitian potong lintang yang dilanjutkan kohort prospektif pada pasien IMA yang dirawat di ICCU RSCM Jakarta, dilakukan November 2018-Mei 2019. Pasien dengan infeksi berat dan sudah mengalami aritmia maligna saat masuk RS dieksklusi. Data karakteristik dasar dan variabel kadar glukosa darah sewaktu, troponin I, VLP, GLS, CaMKII pertama dan hsCRP diambil pada hari pertama perawatan. Kejadian aritmia maligna sebagai luaran utama penelitian dan kadar CaMKII kedua dinilai pada hari ke-5 perawatan. Pasien yang meninggal sebelum hari perawatan ke-5 bukan akibat aritmia maligna dikeluarkan dari penelitian. Hubungan hiperglikemia akut dengan VLP dan kejadian aritmia maligna dianalisis dengan uji chi-square, sedangkan troponin I, GLS, CaMKII dan hsCRP berdasarkan status hiperglikemia diuji dengan uji-t atau Mann-Whitney. Sejumlah 110 pasien diikutkan dalam penelitian, 2 pasien meninggal pada hari ke-3 perawatan akibat aritmia maligna. Tidak ditemukan hubungan bermakna antara hiperglikemia akut pada IMA dengan aritmia maligna. Pada analisis bivariat, CaMKII hari ke-1 dan ke-5 memiliki hubungan bermakna dengan kejadian aritmia maligna (p = 0,03, p = 0,01). Pada kelompok hiperglikemia akut terdapat perbedaan kadar CaMKII di hari ke-5 antara VLP positif dan negatif (p = 0,03). Disimpulkan bahwa IMA pada fase awal akan menimbulkan kerusakan miokard yang lebih dominan dibandingkan peran metabolik. Fase berikutnya terjadi peningkatan katekolamin yang berakibat terjadinya hiperglikemia akut dan akan meningkatkan ROS serta aktivasi perubahan kanal ion yang digambarkan dengan CaMKII. Perubahan ini berakibat remodeling elektrofisiologi jantung yang terlihat dari gambaran VLP pada pemeriksaan SA-ECG. Kata Kunci: Aritmia maligna, CaMKII, Hiperglikemia Akut, hsCRP, IMA, VLP

---

Acute Myocardial Infarction (AMI) is often followed by hyperglycemia which will increase the risk of malignant arrhythmias through mechanisms that are thought to be myocardial damage, ion channel changes and increased inflammatory response.There have been many studies on the correlation of acute hyperglycemia with the occurrence of malignant arrhythmias in acute coronary syndromes (ACS), but not much in AMI as a special population of ACS with a higher risk of malignant arrhythmias.There are no studies that examine the role of myocardial damage, ion channel changes and increased inflammatory response as a pathomechanism of malignant arrhythmias in AMI patients. The purpose of this study was to determine the effect of acute hyperglycemia on the occurence of malignant arrhythmias, troponin I, VLP, echocardiographic strain, ion channel changes (CaMKII) and hsCRP. This study also aims to assess the effect of troponin I, VLP, GLS, CaMKII and hsCRP on the occurence of malignant arrhythmias in AMI patients with acute hyperglycemia. A cross-sectional study followed by a prospective cohort of AMI patients treated at ICCU Cipto Mangunkusumo Hospital Jakarta was done from November 2018– May 2019. Patients with severe infections and who had experienced malignant arrhythmias at admission were excluded. Data on baseline characteristics and random blood glucose levels, troponin I, VLP, GLS, the first CaMKII and hsCRP were collected on the first day of treatment. The occurence of malignant arrhythmias as the main outcome of this study and the second CaMKII level were assessed on the fifth day of treatment. Patients who died before the fifth day of treatment not due to malignant arrhythmias were excluded. The correlation between acute hyperglycemia with VLP and the occurence of malignant arrhythmias was analyzed by chi-square test, whereas troponin I, GLS, CaMKII and hsCRP based on the hyperglycemia status were tested by t-test of Mann-Whitney test. A total of 110 patients were included in the study, 2 patients died on the third day due to malignant arrhythmias. No significant relationship was found between acute hyperglycemia in AMI and malignant arrhythmias. On the first day and fifth day CaMKII bivariate analysis had a significant correlation with the occurence of malignant arrhythmias (p = 0.03, p = 0.01, respectively). In the acute hyperglycemia group there were differences in CaMKII levels on the fifth day between positive and negative VLP (p = 0.03). It was concluded that AMI in the initial phase would cause more dominant myocardial damage compared to the role of metabolic factors. In the next phase there is an acute hyperglycemia and will increase ROS and activation of ion channel changes described by CaMKII. This change results in the electrophysiological remodeling of the heart as seen from the VLP picture on SA-ECG. Key Words: Acute hyperglycemia, AMI, CaMKII, hsCRP, Malignant arrhythmias, VLP

Abstrak :
Penggantian katup aorta dengan katup mekanik memerlukan biaya mahal, meningkatkan risiko endokarditis dan tromboemboli, serta memerlukan antikoagulan seumur hidup. Perikardium autolog merupakan alternatif untuk penggantian katup aorta. Tujuan penelitian ini adalah membandingkan luaran penggantian katup aorta antara katup mekanik dan perikardium autolog dengan teknik strip tunggal perikardium. Penelitian ini merupakan uji klinis terandomisasi di Pelayanan Jantung Terpadu Rumah Sakit Cipto Mangunkusumo (PJT-RSCM). Subjek dibagi ke dalam 2 kelompok berdasarkan jenis katup yang diterima, yaitu katup mekanik (kelompok mekanik) dan strip perikardium (kelompok strip). Luaran left ventricular reverse remodeling (LVRR), 6 minute walking test (6MWT), dan kadar soluble suppression of tumorigenicity-2 (sST-2) diperiksa preoperasi, 3 bulan, dan 6 bulan pascabedah. Terdapat 34 subjek yang ikut serta dari Juli 2016-Februari 2022, 17 subjek pada masing-masing kelompok. Tidak terdapat beda kejadian LVRR pada kedua kelompok, yaitu 26,7% pada kelompok mekanik dan 29,4% pada kelompok strip (p = 0,703). Pada pemeriksaan jarak 6 minute walking test (6MWT) tidak terdapat perbedaan bermakna jarak 6MWT antara kelompok strip perikardium dan kelompok mekanik pada 6 bulan pascabedah, yaitu 431,93 (SB 93,41) m vs. 404,28 (SB 79,25) m, p = 0,427 pascabedah. Kadar sST-2 kelompok mekanik 16,12 (SB 5,92) pg/mL secara bermakna lebih tinggi dibandingkan kelompok strip 11,52 (SB 6,96) pg/mL, p = 0,023) pada 6 bulan pascabedah. Disimpulkan teknik strip tunggal perikardium memiliki luaran yang sebanding dengan katup mekanik sehingga dapat digunakan sebagai alternatif penggantian katup aorta. ......Aortic valve replacement with mechanical valves are quite expensive, increased the risk of adverse events such as endocarditis and thromboembolism, and requires patients to take anticoagulants for the rest of their life. Autologous pericardium is an alternative for aortic valve replacement. This study aims to compare outcomes of aortic valve replacement using mechanical valve and prosthetic valve with single-strip pericardium technique. This was a randomized clinical trial conducted at the Cipto Mangunkusumo Hospital (PJT-RSCM). Eligible subjects were randomized to either receive mechanical valve (mechanical group) or single-strip pericardium (single-strip group). Outcome assessments of left ventricular reverse remodeling (LVRR), 6 minute walking test (6MWT), and soluble suppression of tumorogenicity-2 (sST-2) were carried out at preoperation, 3 months, and 6 months postoperation. There were 34 subjects recruited from July 2016 to February 2022, 17 subjects in each groups. There was no difference in postoperative LVRR incidence between both groups, 26.7% in mechanical group vs. 29.4% in single strip group (p = 0.703). There was no significant difference of 6MWT between the mechanical and pericardial strip at six months post-operation, 404.28 (SD 79.25) m vs. 431.93 (SD 93.41) m, p = 0.427. The sST-2 level is significantly higher in mechanical group 16.12 (SD 5.92) pg/mL compared to single strip group 11.52 (SD 6.96) pg/mL, p = 0.023 at six months post-operation. We concluded that single strip pericardium technique showed comparable outcomes to mechanical valve and is considered a feasible alternative for aortic valve replacement.

Abstrak :
Infark miokard menyebabkan kematian kardiomiosit dan remodeling jantung pada situasi patologis. Pascainfark jantung tidak mampu mengatasi kehilangan kardiomiosit meskipun telah dilakukan rekanalisasi atau revaskularisasi. Oleh karena itu, diperlukan metode untuk mengembalikan fungsi jantung. Sel punca dapat memperbaharui diri dan berdiferensiasi menjadi berbagai tipe sel namun kesintasannya pada pasien masih rendah. Untuk meningkatkan retensi dan regenerasi sel punca di miokardium dapat digunakan perancah/scaffold dan sistem ko-kultur, namun belum ada penelitian tentang hal tersebut. Penelitian ini bertujuan mengembangkan terapi infark menggunakan injeksi hidrogel transepikardial dan implantasi di epikardial perancah patch membran amnion yang dideselularisasi menggunakan amniotic epithelial cells (AEC) dengan ko-kultur kardiomiosit. Penelitian ini menggunakan post-test only control group design yang dilakukan di Institut Pertanian Bogor dan Fakultas Kedokteran Universitas Indonesia dari Juli 2021–Oktober 2022. Subjek penelitian adalah 15 babi Sus scrofa domesticus usia 2-3 bulan dibagi tiga kelompok: pAEC, pAEC + kardiomiosit, kontrol positif, dan 1 babi sebagai kontrol negatif. Torakotomi dilakukan untuk membuat model infark dengan ligasi arteri proximal branch to left ventricle (PLV) dilanjutkan implantasi pAEC dengan atau tanpa ko-kultur kardiomiosit pada kelompok terapi, kemudian diobservasi selama 6–8 minggu. Luas infark diukur dengan late gadolinium enhancement MRI; remodeling ventrikel kiri dengan ekokardiografi untuk menilai kontraktilitas, fibrosis dengan IHK, kardiomiogenesis dan regulasi apoptosis dengan RT-PCR, angiogenesis dinilai dengan IHK, dan fraksi ejeksi dinilai dengan ekokardiografi. Luas infark menurun pada kedua kelompok terapi (2,5 [2,00–3,00]% dan 3,60 ± 1,34% vs 9,50 ± 1,91%). Pewarnaan HE dan Masson trichrome menunjukkan berkurangnya proses fibrosis pada kedua kelompok, dikonfirmasi dengan hiperekspresi kolagen1 yang padat dan kaku pada kontrol positif dibandingkan kedua kelompok terapi yang memiliki ekspresi kolagen3 lebih dominan. Ekspresi α-smooth muscle actin pada kedua kelompok tampak tersebar menunjukkan penurunan fibrosis dan kontrol positif menunjukkan peningkatan fibrosis. Peningkatan kardiomiogenesis pada kedua kelompok dikonfirmasi dengan peningkatan ekspresi gen cardiac troponin T, gen myosin heavy chain, gen Nkx.2.5, gen c-Kit, dan penanda otot fungsional α-actinin. Penurunan apoptosis dikonfirmasi dengan penurunan ekspresi gen modulator apoptosis p21 dan ekspresi gen p53 yang berarti diferensiasi sel punca tidak bersifat tumorigenik. Regulasi apoptosis melalui ekspresi kaspase-9 tidak berbeda bermakna. Peningkatan angiogenesis dikonfirmasi dengan peningkatan ekspresi von Willebrand Factor dan ekspresi α-smooth muscle actin yang tersebar. Ekokardiografi menunjukkan perbaikan regional wall motion abnormality lebih banyak pada kelompok terapi daripada kontrol positif dan fraksi ejeksi tidak berbeda bermakna antar kelompok. Disimpulkan kombinasi injeksi hidrogel transepikardial dan implantasi di epikardial perancah patch membran amnion yang dideselularisasi dengan ko-kultur AEC dan kardiomiosit dapat mengurangi luas infark dan remodelling ventrikel kiri, serta meningkatkan angiogenesis pada babi model infark. ......Myocardial infarction induces cardiomyocyte death and remodelling a pathological condition. The post-infarct heart is unable to deal with cardiomyocyte loss despite recanalization or revascularization. Therefore, a procedure is required to restore cardiac function. Stem cells can self-renew and specialize into multiple cell types however the survival of stem cells in patients is still poor. To promote the retention and regeneration of stem cells in the myocardium, scaffolds and co-culture systems may be applicated, although there are no study findings on this issue. This study aimed to develop myocardial infarction therapy using transepicardial hydrogel injection and epicardial decellularized amniotic membrane scaffold patch implantation using amniotic epithelial cells (AEC) with cardiomyocyte co-culture. This study used a post-test-only control group design performed at the IPB University and the Faculty of Medicine, Universitas Indonesia, from July 2021 to October 2022. The study subjects were 15 Sus scrofa domesticus pigs aged 2-3 months placed into three groups: pAEC, pAEC + cardiomyocytes, positive control, and 1 pig as a negative control. Thoracotomy was conducted to create an infarct model with the proximal branch to left ventricle (PLV) artery occlusion followed by pAEC implantation with or without cardiomyocyte co-culture in the therapy group, then evaluated for 6–8 weeks. Infarct size was determined by late gadolinium enhancement MRI, left ventricular remodeling by echocardiography to evaluate contractility, fibrosis by IHC, cardiomyogenesis and regulation of apoptosis by RT-PCR, angiogenesis was assessed by IHC, and ejection fraction by echocardiography. Infarct size reduced in both therapy groups (2,5 [2,00–3,00]% and 3,60 ± 1,34% vs 9,50 ± 1,91%). HE and Masson trichrome staining demonstrated decreased fibrosis in both groups, confirmed by hyperexpression of dense and stiff collagen 1 in the positive control compared to the two therapy groups with more dominant collagen 3 expressions. The α-smooth muscle actin expression in both groups seemed to be scattered suggesting reduced fibrosis while the positive control showed increased fibrosis. Increased cardiomyogenesis in both groups was confirmed by increased expression of the cardiac troponin T gene, the myosin heavy chain gene, the Nkx.2.5 gene, the c-Kit gene, and the functional muscle marker α-actinin. The reduction in apoptosis has been confirmed by lower expression of the p21 apoptosis modulator gene and p53 gene expression, which suggests that stem cell differentiation is not tumorigenic. The control of apoptosis by caspase-9 expression was not significantly different. Increased angiogenesis was verified by increased von Willebrand Factor expression and scattered expression of α-smooth muscle actin. Echocardiography showed greater improvement in regional wall motion abnormalities in the therapy groups than in the positive control, and the ejection fraction was not significantly different between groups. It was concluded that the combination of transepicardial hydrogel injection and epicardial decellularized amniotic membrane scaffold patch implantation using AEC with cardiomyocyte co-culture could reduce infarct size and left ventricular remodeling, as well as increase angiogenesis in infarct model pigs.

Abstrak :
Perubahan tunika intima media (TIM) karotis dan flow mediated dilatation (FMD) dapat digunakan sebagai pemeriksaan untuk mengetahui aterosklerosis dini. Pada ODHA TIM karotis dan FMD dapat dipengaruhi oleh inflamasi kronik akibat infeksi HIV itu sendiri, efek samping terapi ARV, dan koinfeksi virus atau bakteri lain. Oleh karena itu, penelitian ini menelaah kinetika penanda inflamasi (CRP, ICAM-1 dan sTNFR), kondroitin sulfat (KS) serta antibodi CMV, mengorelasikannya dengan perubahan TIM karotis dan FMD pada ODHA yang memulai terapi ARV serta dibandingkan dengan kontrol sehat setelah 60 bulan terapi ARV. Desain penelitian kohort prospektif dan cross-sectional. Subjek penelitian didapatkan dengan consecutive sampling dari Januari 2013 sampai Desember 2014, diamati dalam 3 kurun waktu selama 60 bulan di RSUPN Dr. Cipto Mangunkusumo. Dilakukan pemeriksaan USG pembuluh darah karotis pada semua subjek, diamati perubahan ketebalan TIM karotis, FMD, kadar CD4, indeks massa tubuh, kadar CRP, ICAM-1, sTNFR, KS, dan antibodi CMV setiap periode pengamatan. Data dianalisis menggunakan uji Mann Whitney U, Wilcoxon, Spearman’s correlation, Pearson’s correlation dan multiple linear regression. Tidak didapatkan perubahan TIM karotis setelah dilakukan terapi ARV selama 12 bulan dan 60 bulan. Tidak ada perbedaan bermakna untuk TIM karotis dan FMD antara ODHA dengan kontrol sehat. ICAM-1 memiliki korelasi dengan TIM karotis pada kunjungan awal sebelum terapi dan KS memiliki korelasi dengan TIM karotis setelah 60 bulan terapi ARV. FMD memiliki korelasi negatif dengan KS dan antibodi CMV lysate pada ODHA, sedangkan pada kontrol sehat FMD memiliki korelasi negatif dengan sTNFR dan KS, namun memiliki korelasi kuat dengan antibodi CMV gB. Inflamasi kronik pada ODHA tidak menyebabkan perubahan TIM karoti. KS dan antibodi CMV lysate dapat memengaruhi nilai FMD pada ODHA. Pada kontrol sehat, KS dan sTNFR bisa memengaruhi nilai FMD, namun antibodi CMV gB bisa berfungsi sebagai faktor pelindung. ......Carotid intima-media thickness (CIMT) and flow mediated dilatation (FMD) used to detect early atherosclerosis. In people living with hiv/aids (PLWH), CIMT and FMD could be influenced by chronic inflammation affected HIV infection, ART and co-infection. We did the research to study the kinetic of inflammation biomarkers (CRP, ICAM-1 and sTNFR), chondroitine sulfate (CS) and CMV reactive antibodies, to find correlation for CIMT and FMD starting ART and compare to healthy control (HC) after 60 months. This was a cohort prospective study and repeated cross sectional. The subjects were collected from January 2013 until December 2014, follow up to 60 months. Every visit we did USG for carotid artery and FMD at brachial artery, CD4, BMI, CRP, ICAM-1, sTNFR, CS and CMV antibodies level were also measured. Data were analyzed using Mann Whitney U, Wilcoxon, Spearman’s correlation, Pearson’s correlation and multiple linear regression. There were no differences in CIMT changes in 60 years follow up. There were no differences of CIMT and FMD between PLWH and HC. ICAM-1 had a correlation with CIMT before starting ARV therapy and CS had a correlation with CIMT after 60 months of ARV therapy. FMD had a negative correlation with CS and CMV Lysate antibody for PLWH. FMD had negative correlation to CS and sTNFR but strong correlation to CMV gB antibody in HC. Chronic inflammation in PLWH did not cause CIMT changes. CS and CMV Lysate antibody may influenced FMD in PLWH, but for HC, CS and sTNFR may influenced FMD, but CMV gB antibody could be a protective factor.

Abstrak :
Intervensi koroner perkutan (IKP) terbukti mengurangi morbiditas dan mortalitas penyakit jantung koroner (PJK). Cedera pembuluh darah akibat IKP dapat menyebabkan timbulnya inflamasi dan stress oksidatif. Studi ini menunjukkan bahwa kurkumin memiliki efek menekan inflamasi dan antioksidan pada penderita PJK stabil pasca-IKP. Penelitian ini bertujuan untuk mengetahui efektivitas suplementasi kurkumin per oral dalam menurunkan kadar inflamasi dan stres oksidatif pasca-IKP pasien PJK stabil. Pasien dewasa PJK stabil dilakukan IKP, dirandomisasi secara acak tersamar ganda ke dalam kelompok kurkumin atau plasebo. Kurkumin (45 mg/hari) atau plasebo diberikan selama 7 hari sebelum IKP hingga 2 hari setelah IKP. Kadar marker inflamasi (hsCRP dan sCD40L) dan marker oksidatif (MDA dan GSH) dalam serum dinilai dalam 3 fase, 7 hari pra-IKP, 24 jam pasca-IKP, dan 48 jam pasca-IKP. Selama periode April–Juni 2015, terdapat 50 pasien yang direkrut (25 kurkumin dan 25 plasebo) di RSUP Cipto Mangunkusumo dan RS Jantung Jakarta. Konsentrasi hsCRP dan sCD40L pada kelompok kurkumin dalam 3 fase cendrung menurun (p < 0,05) dibanding kelompok plasebo, tetapi konsentrasi hsCRP dan sCD40L pada tiap fase tidak berbedaan bermakna, sedang kadar MDA dan GSH tidak berbeda bermakna setiap fase, namun menunjukkan kecenderungan penurunan kadar MDA (p = 0,6) dan GSH (p = 0,3). Pemberian kurkumin mempunyai kecenderungan menurunkan respons inflamasi pasca-IKP dan cenderung menghambat pembentukan stress oksidatif yaitu MDA serum melalui mekanisme peningkatan penggunaan antioksidan internal yaitu GSH serum. ......Background: Percutaneous coronary intervention (PCI) has been proven to improve morbidities and mortalities in stable coronary heart disease (CHD). However, ischemia-reperfusion injury resulted from PCI might induce inflammation and oxidative stress. Several studies suggested that curcumin exerts anti-inflammatory and antioxidant properties that may be beneficial in post-PCI stable CHD patients. Objectives: To determine the efficacy of orally administered curcumin in reducing inflammatory response and oxidative stress in post-PCI of stable CHD patients. Methods: A double-blind randomized controlled trial consisting of 50 adult patients of both sexes with stable CHD who underwent PCI were treated with curcumin or placebo. Either curcumin (45 mg/day) or placebo was given 7 days prior to PCI until 2 days after PCI. Inflammatory markers (hsCRP and sCD40L) and oxidative stress assessment (MDA and GSH) were measured in 3 phases (7 days pre-PCI, 24 hours post-PCI, and 48 hours post-PCI). Results: During April–June 2015, 50 patients were recruited (25 curcumin and 25 placebo) from Cipto Mangunkusumo General Hospital and Jakarta Heart Center. The serum concentrations of hsCRP and sCD40L in curcumin group (p < 0.05) in all observation phases were significantly lower compared with placebo group; however, there were no significant differences between groups. No significant difference was observed among phases in MDA and GSH, but there was a trend of decreasing MDA and GSH levels (p = 0.6 and p = 0.3, respectively) in curcumin group. Conclusion: Curcumin tends to reduce inflammatory response following PCI by decreasing oxidative stress (MDA) through the increase of internal antioxidant utilization (GSH).